Dr. Somnath Chatterjee has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, a promoter of Suraksha Diagnostic Limited, has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and persons holding 5% or more to disclose changes in their shareholding exceeding 2% within a financial year (creeping acquisition or disposal). The headline does not specify whether this was a purchase or sale, nor the exact quantum or direction of the change. The detailed disclosure document, when published, will contain the specifics of the transaction.
This is a routine compliance filing and not by itself a major ownership event. However, it does signal incremental movement (upward or downward) in promoter shareholding, and retail investors should review the actual disclosure to see if the promoter is buying or selling and whether it shifts the promoter holding meaningfully.